Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Claritin

This article was originally published in The Tan Sheet

Executive Summary

Consumer coalition lawsuit against Schering-Plough claims non-sedating antihistamine DTC ads misleadingly imply higher degree of efficacy than has been proven. Prescription Access Litigation Project seeks refunds for consumers' costs of potential switch drug. Schering's legal battles also extend to GMP problems; on Aug. 9, Public Citizen renewed request for criminal investigation into firm's recall of 59 mil. Rx albuterol inhalers
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel